4//SEC Filing
Alder Matthias 4
Accession 0001209191-23-059558
CIK 0001819411other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:17 PM ET
Size
9.3 KB
Accession
0001209191-23-059558
Insider Transaction Report
Form 4
Alder Matthias
CHIEF OPERATING OFFICER
Transactions
- Exercise/Conversion
Common Stock
2023-12-20+637→ 5,492 total - Exercise/Conversion
Restricted Stock Units
2023-12-20−637→ 7,013 total→ Common Stock (637 underlying) - Sale
Common Stock
2023-12-21$2.46/sh−206$507→ 5,286 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.4602 to $2.485 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The RSUs vested 25% on September 20, 2023 and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Gain Therapeutics, Inc.
CIK 0001819411
Entity typeother
Related Parties
1- filerCIK 0001370820
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:17 PM ET
- Size
- 9.3 KB